Anti-Borrelia recombinant IgM ELISA kit, 96 tests

(Cat#: ODZ-399)
Description

The ELISA-VIDITEST anti-Borrelia recombinant IgM (CSF) kit is intended for the detection of IgM antibodies to the pathogenic borrelia strains (B. afzelii, B. garinii and B. burgdorferi sensu stricto) in human serum or plasma, cerebrospinal fluid and synovial fluid. The detection of antibodies is one of the laboratory tests that help to diagnose Lyme disease. 

This assay is a solid-phase immuno-analytical test. The polystyrene strips are coated with the mixture of recombinant antigens. Anti-borrelia antibodies in serum samples bind to the immobilized antigens. The serum antibodies that do not bind are washed away and those that formed complexes with the antigens are later recognized by animal anti-human IgG antibodies labeled with horseradish peroxidase. The presence of labeled antibodies is revealed by an enzymatic reaction with a chromogenic substrate. Negative sera do not react and the mild change in color, if present, may be attributed to the reaction background.

 

  • Solid-phase immuno-analytical test for the detection of IgM antibodies
  • Used with human serum or plasma, cerebrospinal fluid and synovial fluid
  • High sensitivity/specificity (99% / 97%)
  • Highly specific recombinant antigens
  • Semi-quantitative evaluation 
  • Intrathecal IgM synthesis determination
  • Antibody determination in serum, cerebrospinal fluid and synovial fluid
  • Detection of Lyme disease
  • ELISA break-away strips coated with specific recombinant antigens, 1 microplate
  • Standard 1, 1.3ml
  • Standard 2, 1.3ml
  • Negative control serum, 1.3ml
  • Anti-human IgM antibodies labeled with horseradish peroxidase (Px-conjugate), 15ml
  • Wash buffer concentrate 10x, 125ml
  • Dilution buffer, 100ml
  • Chromogenic substrate (TMB substrate), 15ml
  • Stop solution, 15ml 

Previously listed as cat# ODZ-281